H-Ras and K-Ras Oncoproteins Induce Different Tumor Spectra When Driven by the Same Regulatory Sequences.

Drosten, Matthias; Simón-Carrasco, Lucía; Hernández-Porras, Isabel; Lechuga, Carmen G; Blasco, María T; Jacob, Harrys K C; Fabbiano, Salvatore; Potenza, Nicoletta et al. · Cancer Res · 2017

basic_science · Level V

Where this comes from

Abstract

Genetic studies in mice have provided evidence that H-Ras and K-Ras proteins are bioequivalent. However, human tumors display marked differences in the association of RAS oncogenes with tumor type. Thus, to further assess the bioequivalence of oncogenic H-Ras and K-Ras, we replaced the coding region of the murine K-Ras locus with H-Ras<sup>G12V</sup> oncogene sequences. Germline expression of H-Ras<sup>G12V</sup> or K-Ras<sup>G12V</sup> from the K-Ras locus resulted in embryonic lethality. However, expression of these genes in adult mice led to different tumor phenotypes. Whereas H-Ras<sup>G12V</sup> elicited papillomas and hematopoietic tumors, K-Ras<sup>G12V</sup> induced lung tumors and gastric lesions. Pulmonary expression of H-Ras<sup>G12V</sup> created a senescence-like state caused by excessive MAPK signaling. Likewise, H-Ras<sup>G12V</sup> but not K-Ras<sup>G12V</sup> induced senescence in mouse embryonic fibroblasts. Label-free quantitative analysis revealed that minor differences in H-Ras<sup>G12V</sup> expression levels led to drastically different biological outputs, suggesting that subtle differences in MAPK signaling confer nonequivalent functions that influence tumor spectra induced by RAS oncoproteins. Cancer Res; 77(3); 707-18. ©2016 AACR.

Medical subject headings